Olanzapine: an exciting atypical antipsychotic -- the preclinical profile

By Moore N.A.   Bymaster F.P.   Calligaro D.O.   Fuller R.W.   Rasmussen K.   Stockton M.E.   D. T.W.   Tye N.C.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 255-256

Elsevier

Access to resources Recommend Favorite

Pharmacokinetic Profile and Clinical Efficacy of Long-Acting Risperidone: Potential Benefits of Combining an Atypical Antipsychotic and a New Delivery System

By Ereshefsky Larry  

Drugs in R&D, Vol. 6, Iss. 3, 2005-01 ,pp. : 129-137

Adis International

Access to resources Recommend Favorite

New 3-benzisothiazolyl and 3-benzisoxazolylpiperazine derivatives with atypical antipsychotic binding profile

By Orjales A.   Mosquera R.   Toledo A.   Pumar C.   Labeaga L.   Innerarity A.  

European Journal of Medicinal Chemistry, Vol. 37, Iss. 9, 2002-09 ,pp. : 721-730

Elsevier

Access to resources Recommend Favorite

Ziprasidone: a new atypical antipsychotic

By Arnold Lesley M   McElroy Susan L   Keck Paul E  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 6, 2001-06 ,pp. : 1033-1042

Informa Healthcare

Access to resources Recommend Favorite

Olanzapine: an atypical antipsychotic for schizophrenia

By Lund B.C.   Perry P.J.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 2, 2000-01 ,pp. : 305-323

Informa Healthcare

Access to resources Recommend Favorite